[Update on therapy of invasive mycoses in hematology and oncology].
Maschmeyer
G
G
Medizinische Klinik, Hämatologie und Onkologie, Klinikum Ernst von Bergmann, Potsdam. gmaschmeyer@klinikumevb.de
Haas
A
A
Böhme
A
A
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D000077336:Caspofungin; D003840:Deoxycholic Acid / Q000627:therapeutic use; D004338:Drug Combinations; D054714:Echinocandins; D019337:Hematologic Neoplasms / Q000150:complications*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D055666:Lipopeptides; D008081:Liposomes; D009181:Mycoses / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D016377:Organ Transplantation / Q000009:adverse effects; D010456:Peptides, Cyclic / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole; D020096:Zygomycosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology
D000935:Antifungal Agents; D004338:Drug Combinations; D054714:Echinocandins; D055666:Lipopeptides; D008081:Liposomes; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D003840:Deoxycholic Acid; D017964:Itraconazole; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination; D000077336:Caspofungin; D065819:Voriconazole